Technical Analysis for TECX - Tectonic Therapeutic, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.76% | |
| Gapped Up | Strength | 0.76% | |
| Bullish Engulfing | Bullish | 8.57% | |
| Multiple of Ten Bullish | Other | 8.57% | |
| Wide Bands | Range Expansion | 8.57% | |
| Multiple of Ten Bearish | Other | 14.10% | |
| Wide Bands | Range Expansion | 14.10% | |
| Down 3 Days in a Row | Weakness | 14.10% | |
| Down 4 Days in a Row | Weakness | 14.10% | |
| Fell Below 20 DMA | Bearish | 9.67% |
| Alert | Time |
|---|---|
| 10 DMA Support | about 2 hours ago |
| Rose Above Previous Day's High | about 2 hours ago |
| Up 3% | about 2 hours ago |
| Down 2 % | about 2 hours ago |
| Down 1% | about 2 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Tectonic Therapeutic is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors ("GPCRs"). Leveraging its proprietary technology platform called GEODe™ ("GPCRs Engineered for Optimal Discovery"), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Antibodies Drug Discovery Molecular Biology Signal Transduction
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Antibodies Drug Discovery Molecular Biology Signal Transduction
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 48.63 |
| 52 Week Low | 12.12 |
| Average Volume | 143,290 |
| 200-Day Moving Average | 20.73 |
| 50-Day Moving Average | 34.08 |
| 20-Day Moving Average | 42.28 |
| 10-Day Moving Average | 43.73 |
| Average True Range | 3.06 |
| RSI (14) | 60.00 |
| ADX | 31.35 |
| +DI | 28.55 |
| -DI | 28.97 |
| Chandelier Exit (Long, 3 ATRs) | 39.44 |
| Chandelier Exit (Short, 3 ATRs) | 43.38 |
| Upper Bollinger Bands | 48.05 |
| Lower Bollinger Band | 36.51 |
| Percent B (%b) | 0.65 |
| BandWidth | 27.28 |
| MACD Line | 2.37 |
| MACD Signal Line | 3.18 |
| MACD Histogram | -0.8093 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 47.79 | ||||
| Resistance 3 (R3) | 47.58 | 46.11 | 47.16 | ||
| Resistance 2 (R2) | 46.11 | 45.15 | 46.22 | 46.95 | |
| Resistance 1 (R1) | 45.07 | 44.56 | 45.59 | 45.28 | 46.74 |
| Pivot Point | 43.61 | 43.61 | 43.87 | 43.71 | 43.61 |
| Support 1 (S1) | 42.57 | 42.65 | 43.09 | 42.78 | 41.32 |
| Support 2 (S2) | 41.10 | 42.06 | 41.21 | 41.11 | |
| Support 3 (S3) | 40.06 | 41.10 | 40.90 | ||
| Support 4 (S4) | 40.27 |
